< previous page page_233 next page >

Page 233
10
Manufacturing Project Management
Stephen R. Self
Merck Generics Ltd.
Kent, England
3a2af372a540e460b69ba6aec2b32999.gif
I. Introduction
233
3a2af372a540e460b69ba6aec2b32999.gif
II. Manufacturing Philosophy
236
3a2af372a540e460b69ba6aec2b32999.gif
III. Many Conflicting Objectives
237
3a2af372a540e460b69ba6aec2b32999.gif
IV. The Changing Demands of Each Phase of Product Development
238
3a2af372a540e460b69ba6aec2b32999.gif
V. An Interlocking Project Structure
244
3a2af372a540e460b69ba6aec2b32999.gif
VI. Manufacturing Project Management Group
246
3a2af372a540e460b69ba6aec2b32999.gif
VII. The Technical Support Structure
248
3a2af372a540e460b69ba6aec2b32999.gif
VIII. Worldwide Production
251
3a2af372a540e460b69ba6aec2b32999.gif
IX. Summary
252
3a2af372a540e460b69ba6aec2b32999.gif
References
252

I.
Introduction
The pharmaceutical industry has faced a very changeable environment in the last ten years. A more competitive market which has been changed structurally by the influence of many more groups involved in purchasing decisions, has led to greater pressure on prices and profits. Complex development programs and the increasing costs of product development have

 
< previous page page_233 next page >